Condition
Visual Field
Total Trials
7
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Unknown2
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06978101CompletedPrimary
Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma
NCT06054763Not ApplicableUnknown
Buyang Huanwu Decoction and Normal Tension Glaucoma
NCT05739487Completed
Changes of Visual Field Defects After IAT for CRAO
NCT04499157Not ApplicableUnknown
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
NCT01021982Completed
Evaluation of Objective Perimetry Using Pupillometer
NCT00441194TerminatedPrimary
To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series
NCT00727168Completed
Screening for Glaucoma in Namil Area, South Korea
Showing all 7 trials